The complete 2026 guide — what cancer treatment in China actually costs, which JCI-accredited hospitals deliver it, and how the escrow structure protects your money at every step.
Updated August 2026. Every year, tens of thousands of Western patients travel to China for cancer care — driven by therapies approved there that are unavailable or unaffordable at home, and by price differences that routinely reach 80–90%. This guide gives you the real numbers, the real hospitals, and the one structural safeguard most agencies won't give you: escrow.
These are typical all-in ranges from JCI-accredited partner hospitals in 2025–2026. "All-in" means hospital fees, physician fees, medications, nursing, room, and coordination — no surprise line items.
| Therapy | Typical US price | China all-in | Savings |
|---|---|---|---|
| CAR-T cell therapy | $500,000+ | ~$60,000 | ~88% |
| Immunotherapy (PD-1/PD-L1) | $150,000–250,000/yr | $25,000–45,000/yr | ~80% |
| Proton therapy | $100,000–180,000 | $30,000–60,000 | ~70% |
| Robotic surgery (Da Vinci) | $60,000–120,000 | $20,000–40,000 | ~65% |
| Radiation (IMRT/SBRT) | $30,000–80,000 | $8,000–18,000 | ~75% |
| Diagnostic workup (PET-CT, biopsy, panels) | $8,000–25,000 | $1,500–4,000 | ~80% |
Why the gap is real: the same CAR-T product approved by China's NMPA and manufactured domestically costs a fraction of US list prices. Drug pricing, hospital economics, and insurance structures are fundamentally different — and the quality standard (JCI accreditation, international physicians) is comparable.
We coordinate with a verified network of hospitals licensed for international patients. The flagship destination is the Hainan Boao Lecheng International Medical Tourism Pilot Zone — China's designated medical tourism free trade zone, where treatments approved abroad (but not yet in mainland China) can be legally used.
In traditional medical tourism, you wire 100% of the fee to an agency before you board the plane. If the hospital doesn't match the brochure — or the agency disappears — your money is gone.
How our escrow works:
You pay the hospital for treatment — not us for "access." Our coordination fee is a separate, disclosed line item, agreed in writing before anything is funded.
The same technology platform, approved by China's NMPA and manufactured domestically. Clinical protocols are reviewed by the hospital's tumor board. Always bring your US records for a full eligibility review — not every patient qualifies for every therapy.
Most US insurers do not cover care abroad. However, many patients still save 70–90% out-of-pocket versus US list prices. We can provide documentation for reimbursement claims where applicable.
For Hainan: no visa for citizens of 86 countries (short stay). For mainland hospitals, we arrange the appropriate medical visa — the process takes 5–10 business days.
Escrow funds are only released as milestones are met. If the hospital cancels, unreleased funds are returned to you in full, minus only documented third-party costs.
Yes. Treating international patients in licensed Chinese hospitals is legal and government-supported. Every program we coordinate is performed by licensed physicians at licensed facilities, under a signed treatment agreement.
Attach your diagnosis in your message. We'll respond within one business day.